Tech Company Financing Transactions
Resolute Science Funding Round
NuFund Venture Group invested in a funding round for Resolute Science. This venture round closed on 2/12/2025.
Transaction Overview
Company Name
Announced On
2/12/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance its lead asset, RS-5, a MAC-TAC carrying an MMAE payload, through IND-enabling studies and submission.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3210 Merryfield Row
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Resolute is developing a novel class of therapeutics for aggressive, difficult-to-treat, and rare solid tumors. Established with a mission to cure solid tumors, we leverage our MAC-TACs (Macrophage Targeted Conjugates) technology platform to design a broad range of biomarker-driven, first-in-class, pan-cancer, synthetic molecules with the potential to deliver superior safety and efficacy over existing standard of care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Faith Barnett
Browse more venture capital transactions:
Prev: 2/12/2025: MarketLeap venture capital transaction
Next: 2/12/2025: Addlly AI venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs